Silence Therapeutics
SLN
#7337
Rank
S$0.69 B
Marketcap
S$14.80
Share price
-3.21%
Change (1 day)
88.39%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): S-$2.53

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.52. In 2025 the company made an earnings per share (EPS) of S-$2.44 a decrease over its 2024 EPS that were of S-$1.28.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.533.78%
2025S-$2.4490.91%
2024S-$1.28-32.65%
2023S-$1.90-5.77%
2022S-$2.02-13.03%
2021S-$2.3210.23%
2020S-$2.1058.5%
2019S-$1.332.94%
2018S-$1.29969.59%
2017S-$0.12-79.18%
2016S-$0.58-3.11%
2015S-$0.60-55%
2014S-$1.333.83%
2013S-$1.28-84.88%
2012S-$8.46134.19%
2011S-$3.61-61.8%
2010S-$9.45-45.65%
2009S-$17.40-1.16%
2008S-$17.604.29%
2007S-$16.8810.54%
2006S-$15.27-22.29%
2005S-$19.65-57.32%
2004S-$46.0339.1%
2003S-$33.0970.67%
2002S-$19.39-25.17%
2001S-$25.915.29%
2000S-$24.61-24.54%
1999S-$32.6126.7%
1998S-$25.74-11.73%
1997S-$29.1672.24%
1996S-$16.93